Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer
- 571 Downloads
The apoptosis and antiapoptotic signaling pathways are important for regulating carcinogenesis and cancer progression, and for determining prognosis. Molecules involved in apoptosis represent potential cancer diagnostic markers and therapeutic targets. The inhibitor of apoptosis protein (IAP) family includes several important molecules involved in apoptosis that might represent such targets. Increasing evidence has demonstrated that the IAP family of proteins is integral for antiapoptotic and nuclear factor-κB signal transduction, and enhanced expression of IAPs contributes to colon carcinogenesis and its poor prognosis, as well as to drug resistance of tumors. X-linked IAP, cIAP1, cIAP2, and survivin are prognostic markers of colorectal cancer, and survivin and cIAP2 are also utilized to predict the effect of anticancer treatment in colorectal cancer patients. Novel therapies such as YM155 and LY2181308 targeting survivin, AEG35156 and phenoxodiol targeting X-linked IAP, AT-406 as a Smac mimetic, and survivin peptides are currently being evaluated in clinical trials. This report reviews the involvement of the IAP family in colorectal adenocarcinoma in order to summarize the role of the IAP family members as diagnostic and therapeutic targets, and to provide an overview of the future course of research in this area.
Key wordsInhibitor of apoptosis protein family Colorectal cancer Diagnostic marker Therapeutic target Clinical trial
Unable to display preview. Download preview PDF.
- 28.Søreide K, Gudlaugsson E, Skaland I, Janssen EA, Van Diermen B, Körner H, et al. Metachronous cancer development in patients with sporadic colorectal adenomas — multivariate risk model with independent and combined value of hTERT and survivin. Int J Colorectal Dis 2008;23:389–400.CrossRefPubMedGoogle Scholar
- 31.De Oliveira Lima F, De Oliveira Costa H, Barrezueta LF, Fujiyama Oshima CT, Silva JA Jr, Gomes TS, et al. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis. Oncol Rep 2009;22:295–303.PubMedGoogle Scholar
- 46.Ascenta Therapeutics. http://www.ascenta.com/development/index.php#at406.